Graham Lewis
- Pharmacology top 5%
- Economics and Econometrics top 10%
- Public Health, Environmental and Occupational Health
- Physiology
- Genetics
- Co-authors
- John AbrahamAndrew WebsterPaul MartinAndrew SmartR.P. EneverDavid S. MadgeMichael M. HopkinsDolores Ibarreta
- Topics
- Pharmaceutical industry and healthcare (6 papers)Pharmaceutical Economics and Policy (5 papers)Crystallization and Solubility Studies (4 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Graham Lewis
18 papers receiving 360 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 147
- Economics and Econometrics 146
- Public Health, Environmental and Occupational Health 73
- Physiology 53
- Genetics 52
Countries citing papers authored by Graham Lewis
This map shows the geographic impact of Graham Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Lewis more than expected).
Fields of papers citing papers by Graham Lewis
This network shows the impact of papers produced by Graham Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Lewis. The network helps show where Graham Lewis may publish in the future.
Co-authorship network of co-authors of Graham Lewis
This figure shows the co-authorship network connecting the top 25 collaborators of Graham Lewis. A scholar is included among the top collaborators of Graham Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Lewis. Graham Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 13 | |
| 3 | 25 | |
| 4 | 58 | |
| 5 | 59 | |
| 6 | The Implications of Pharmacogenetics and Pharmacogenomics for Drug Development and Health Care | 3 |
| 7 | 36 | |
| 8 | 14 | |
| 9 | Regulating Medicines in Europe: Competition, Expertise and Public Health | 85 |
| 10 | 39 | |
| 11 | 19 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 17 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 5 | |
| 18 | 12 |
About Graham Lewis
Graham Lewis is a scholar working on Pharmacology, Filtration and Separation and Economics and Econometrics, having authored 18 papers that have together received 401 indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (6 papers), Pharmaceutical Economics and Policy (5 papers) and Crystallization and Solubility Studies (4 papers). The work is most often cited by research in Pharmacology (147 citations), Economics and Econometrics (146 citations) and Toxicology (12 citations). Graham Lewis has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include John Abraham, Andrew Webster, Paul Martin, Andrew Smart, R.P. Enever, David S. Madge, Michael M. Hopkins, Dolores Ibarreta, Christien Enzing and Symone Detmar. Their work appears in journals such as The Lancet, Nature Biotechnology and Nature Reviews Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.